GENMAB A/S

SEC Form 4 insider trading activity

GENMAB A/S has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Dec 30, 2025.

On the most recent filing, GENMAB A/S is listed as 10% Owner at Merus N.V. Inside the rolling window, GENMAB A/S reported 9 open-market purchases totaling $7.6B in MRUS and no open-market sales. The largest disclosed transaction in the window is a purchase of 76,920,005 MRUS shares on Dec 29, 2025, worth $7.5B.

Companies traded

Other insiders at MRUS

Insider Buying

$7.6B

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MRUSPurchase$14.1MDec 30SEC ↗
MRUSPurchase$7.5BDec 30SEC ↗
MRUSPurchase$1.5MDec 29SEC ↗
MRUSPurchase$54.4MDec 29SEC ↗
MRUSPurchase$9.3MDec 29SEC ↗
MRUSPurchase$20.6MDec 22SEC ↗
MRUSPurchase$6.4MDec 22SEC ↗
MRUSPurchase$11.7MDec 18SEC ↗
MRUSPurchase$14.6MDec 18SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has GENMAB A/S made?

GENMAB A/S has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does GENMAB A/S trade?

GENMAB A/S has filed SEC Form 4 disclosures for 1 company, including MRUS.

When was GENMAB A/S's most recent SEC Form 4 filing?

GENMAB A/S's most recent SEC Form 4 filing on Tracefour is dated Dec 30, 2025.

What is GENMAB A/S's total buy and sell value in the current window?

Inside the rolling retention window, GENMAB A/S bought $7.6B and sold $0 based on SEC Form 4 filings.

What was GENMAB A/S's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 76,920,005 MRUS shares on 2025-12-29, worth $7.5B, per SEC Form 4 filings.